IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q2 2024 Holdings

Filed 2024-08-13 | 4 holdings | $178.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biohaven LTD(BHVN)COMG1110E107$101.9M2,936,50757.0%
Cytokinetics, Inc(CYTK)COM23282W605$53.1M980,39229.7%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$23.8M3,846,15413.3%
Viracta Therapeutics IncCOM92765F108$2.0K3,7000.0%